Adage Capital Partners Gp, L.L.C. Cabaletta Bio, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

  • $54.9 Billion
  • Q4 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,634,473 shares of CABA stock, worth $8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,634,473
Previous 3,036,645 19.69%
Holding current value
$8 Million
Previous $14.3 Million 44.22%
% of portfolio
0.01%
Previous 0.03%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$1.87 - $4.91 $1.12 Million - $2.94 Million
597,828 Added 19.69%
3,634,473 $8 Million
Q1 2024

May 15, 2024
SELL
$16.79 - $25.38 $3.86 Million - $5.84 Million
-230,000 Reduced 7.04%
3,036,645 $51.8 Million
Q2 2023

Aug 14, 2023
BUY
$7.65 - $13.95 $5.55 Million - $10.1 Million
725,000 Added 28.52%
3,266,645 $42.2 Million
Q4 2021

Feb 14, 2022
SELL
$3.36 - $14.64 $1.68 Million - $7.32 Million
-500,000 Reduced 16.44%
2,541,645 $9.63 Million
Q1 2021

May 17, 2021
SELL
$10.39 - $14.53 $1.45 Million - $2.02 Million
-139,160 Reduced 4.37%
3,041,645 $33.8 Million
Q4 2020

Feb 16, 2021
SELL
$9.81 - $15.8 $2.2 Million - $3.54 Million
-223,955 Reduced 6.58%
3,180,805 $39.7 Million
Q3 2020

Nov 16, 2020
SELL
$9.71 - $14.41 $1.56 Million - $2.31 Million
-160,249 Reduced 4.5%
3,404,760 $36.9 Million
Q2 2020

Aug 14, 2020
SELL
$6.39 - $11.28 $254,008 - $448,391
-39,751 Reduced 1.1%
3,565,009 $39.7 Million
Q1 2020

May 15, 2020
SELL
$6.0 - $18.67 $822,996 - $2.56 Million
-137,166 Reduced 3.67%
3,604,760 $26.3 Million
Q4 2019

Feb 14, 2020
BUY
$7.88 - $17.71 $29.5 Million - $66.3 Million
3,741,926 New
3,741,926 $52.3 Million

Others Institutions Holding CABA

# of Institutions
115
Shares Held
39.6M
Call Options Held
297K
Put Options Held
98.6K
View Full List

About Cabaletta Bio, Inc.

CABA Quotes by TradingView
  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $63.8M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email